|
CNIH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.117800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.332240E-01 |
| Normal-vs-Stage2 |
1.545980E-01 |
| Normal-vs-Stage3 |
5.398800E-01 |
| Normal-vs-Stage4 |
4.239200E-01 |
| Stage1-vs-Stage2 |
5.165600E-01 |
| Stage1-vs-Stage3 |
4.868200E-01 |
| Stage1-vs-Stage4 |
8.564200E-01 |
| Stage2-vs-Stage3 |
2.884800E-01 |
| Stage2-vs-Stage4 |
5.291400E-01 |
| Stage3-vs-Stage4 |
7.477800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.978800E-01 |
| Normal-vs-AfricanAmerican |
1.248210E-01 |
| Normal-vs-Asian |
4.961200E-01 |
| Caucasian-vs-AfricanAmerican |
4.624600E-01 |
| Caucasian-vs-Asian |
9.876000E-01 |
| AfricanAmerican-vs-Asian |
5.002000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.928800E-01 |
| Normal-vs-Female |
5.596200E-02 |
| Male-vs-Female |
1.850980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.511240E-01 |
| Normal-vs-Age(41-60Yrs) |
4.704400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.080000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.324800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.391200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.240400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.816000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.063200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.768800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.797200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.371800E-01 |
| Classical-VS-Follicular |
8.258600E-01 |
| Classical-VS-Other |
3.771800E-01 |
| Classical-VS-Normal |
8.256300E-02 |
| Tall-VS-Follicular |
9.315200E-01 |
| Tall-VS-Other |
3.611000E-01 |
| Tall-VS-Normal |
2.742000E-01 |
| Follicular-VS-Other |
4.596000E-01 |
| Follicular-VS-Normal |
1.826970E-01 |
| Other-VS-Normal |
6.246400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.430200E-01 |
| Normal-vs-N1 |
6.090400E-01 |
| N0-vs-N1 |
1.988850E-01 |
|
|
